GSTP1 Polymorphism, Cigarette Smoking and Cervical Cancer Risk in Korean Women.
10.3349/ymj.2002.43.6.712
- Author:
Sun Ha JEE
1
;
Jong Eun LEE
;
Sook KIM
;
Ji Hyun KIM
;
Soo Jong UM
;
Sung Jong LEE
;
Sung Eun NAMKOONG
;
Jong Sup PARK
Author Information
1. Department of Epidemiology and Health Promotion, Graduate School of Health Science and Management, Yonsei University, Seoul, Korea.
- Publication Type:Original Article ; Research Support, Non-U.S. Gov't
- Keywords:
Polymorphism;
GSTP1;
cervical cancer;
smoking
- MeSH:
Adult;
Aged;
Cervix Neoplasms/*etiology/genetics;
Female;
Glutathione Transferase/*genetics;
Human;
Isoenzymes/*genetics;
Loss of Heterozygosity;
Middle Age;
Polymorphism (Genetics);
Risk;
Smoking
- From:Yonsei Medical Journal
2002;43(6):712-716
- CountryRepublic of Korea
- Language:English
-
Abstract:
Previous studies have suggested that glutathione S-transferase (GST) genotypes may play a role in determining susceptibility to cervical cancer, though the data have often been conflicting. The objective of this study was to examine the effect of GSTP1 polymorphism on cervical carcinogenesis. The studied subjects, patients who were pathologically diagnosed with invasive cervical cancer yielding positive results for human papillomavirus (HPV) (n=342), were compared to healthy, normal, female controls (n=707). DNA from peripheral blood samples from studied subjects whose GSTP1 specific sequences had been determined by PCR with allele-specific primers were reviewed in comparison with the normal controls. The genetic susceptibility of GSTP1 (11q 13.1) in cervical carcinogenesis was determined by examining the effect of gene and environmental factors by the different histopathologic types of invasive cervical cancers. In assessing polymorphism GSTP1, the percentages of individuals homozygous for the A allele, homozygous for the G allele, and heterozygous for the two alleles were 66.8%, 3.9%, and 29.3%, respectively, in the control group, and 64.3%, 4.1%, and 31.6%, respectively, among in women with cervical cancer. Compared with GSTP1 G allele positive (GA or G/G), the odds ratio (OR) (95% confidence interval) for GSTP1 A/A was 1.0 (0.7 - 1.4) for invasive cervical cancer. However, the risk increased with GSTP1 A/A among ever smokers (3.9, 1.7 - 8.9, p-value=0.0012) compared with GSTP1 G allele positive among nonsmokers. In particular, this risk was higher among women with squamous cell carcinoma (4.7, 2.0 - 10.8, p=0.0003). Polymorphism of GSTP1 among smoking women was associated with a higher risk of developing cervical cancer.
